Gloria Ortiz, M.D.
Internal Medicine, Endocrinology, Diabetes & Metabolism (M.D.) with Gloria Ortiz, MD, P.A., practicing in McAllen, Texas. In 2024 Medicare paid $424,613 for 514 patients, and Part D covered 1,472 of their prescriptions, 44% of them generic. Novo Nordisk Inc was the largest of 11 companies reporting payments in 2025, $103,213 in all, mostly speaking and faculty fees. Lists Doctors Hosptal at Renaissance and 1 other hospital as hospital affiliations.
Overview
| NPI | 1871825307 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | Yes |
| NPI issued | Feb 9, 2010 |
| Last updated in NPPES | Oct 22, 2019 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Endocrinology, Diabetes & Metabolism Primary | 207RE0101X | P9426 | TX |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Endocrinology (TX) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 514 |
|---|---|
| Services billed | 13,327 across 53 procedure codes |
| Paid by Medicare | $424,613 |
Part D prescriptions in 2024
| Prescriptions (claims) | 1,472 · 3,450 30-day fills |
|---|---|
| Patients | 452 |
| Total drug cost | $550,790 |
| Generic share | 44% of claims |
Education and affiliations
| Graduation year | 2002 |
|---|---|
| Medicare specialty | Endocrinology |
| Telehealth | Offers telehealth |
Medical group
- Gloria Ortiz, MD, P.A.McAllen, TX · 3 clinicians
Hospital affiliations
- Doctors Hosptal at RenaissanceEdinburg, TX
- Rio Grande Regional HospitalMcAllen, TX
Industry payments (Open Payments)
- 2025$103,213 · 131 payments from 11 companies
- 2024$69,088 · 94 payments from 15 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Novo Nordisk Inc | $48,342 | 43 |
| Lilly USA, LLC | $37,314 | 45 |
| Ascendis Pharma Endocrinology Inc | $6,710 | 11 |
| Bayer Healthcare Pharmaceuticals Inc. | $5,058 | 3 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $5,021 | 5 |
What the 2025 payments were for
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$95,045 · 64 payments
- Travel and Lodging$4,314 · 11 payments
- Food and Beverage$2,924 · 54 payments
- Consulting Fee$930.00 · 2 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Endocrinology, Diabetes & Metabolism providers in McAllen
- 1669980058
- 1033926944
- 1972515708
- 1235286857
- 1821107673
- 1467494112
- 1164806360
- 1699868331
All Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Texas →